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Differential effect ofpolyunsaturated fatty acids on cell proliferation during
human epithelial in vitro carcinogenesis: involvement of epidermal growth
factor receptor tyrosine kinase
S Mollerup and A Haugen
Department of Toxicology, National Institute of Occupational Health, PO Box 8149 Dep, N-0033 Oslo, Norway.
Summary Polyunsaturated fatty acids (PUFAs) have been implicated in tumour development and have been
shown to influence cell proliferation in vitro. We report here that n-3 and n-6 PUFAs at concentration > 10 gM
inhibited the proliferation of a human kidney epithelial cell line (2IHKE), which has retained phenotypic
characteristics of normal kidney epithelial cells. In contrast, the proliferation was stimulated by n-3 and n-6
PUFAs at concentrations <10 gM under defined growth conditions. The stimulatory effect of n-3 and n-6
PUFAs was even more profound in the presence of EGF. In human kidney epithelial cell lines reflecting
different stages of transformation (1IHKE and ITHKEras), the stimulatory effect was abrogated both in the
presence and absence of EGF. Saturated fatty acids did not show any stimulatory effect on cell growth. The
tyrosine kinase inhibitors genistein and tyrphostin-47 inhibited EGF-induced protein tyrosine phosphorylation
dose-dependently in the 2IHKE cells, and abolished the growth stimulatory effect of docosahexaenoic acid
(DHA). This indicates the involvement of EGF receptor tyrosine kinase activity in the observed increase in cell
proliferation.
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Evidence from epidemiological studies suggests that dietary
fat may affect the aetiology of cancer, notably breast cancer
(Howe et al., 1991) and colorectal cancer (Miller et al., 1983;
Nicholson et al., 1988). Polyunsaturated fatty acids (PUFAs)
ofthe n-6 class have in animal models been shown to increase
chemically induced tumour development, possibly by
affecting mainly post-initiation stages. Also the growth of
transplant tumours may be enhanced by n-6 PUFAs (Reddy
and Maruyama, 1986; Cave, 1991; Reddy et al., 1991; Rose
et al., 1993). In contrast, n-3 PUFAs have frequently been
shown to inhibit tumour development in experimental studies
(Karmali et al., 1984; O'Connor et al., 1989; de Bravo et al.,
1991; Rose and Connolly, 1993; Mtehle et al., 1995). This has
been supported in a human study on fish diet (rich in n-3
PUFAs) and breast cancer rates (Kaizer et al., 1989). In vitro,
the inhibitory effect of PUFAs on cell proliferation has been
well documented (Morisaki et al., 1982; Begin et al., 1986;
Rose and Connolly, 1991; H0stmark and Lystad, 1992;
Krokan et al., 1993; Mzehle et al., 1995).
The mechanisms involved in modulation of tumour
development by PUFAs are unknown. Lipid peroxidation,
however, is considered a major contributing factor (reviewed
in Gonzalez, 1992), which is supported by the observation
that antioxidants may abolish the growth-inhibitory effect of
PUFAs (H0stmark and Lystad, 1992). The differential effect
of n-6 and n-3 PUFAs on tumour development has been
explained by increased production of peroxidation products
with increasing chain length or degree of unsaturation of the
fatty acids, correlating grossly with PUFA classes (Begin,
1989; H0stmark and Lystad, 1992; Krokan et al., 1993). In
addition, exposure to n-6 PUFAs promotes increased
synthesis of arachidonic acid-derived cyclooxygenase- and
lipoxygenase-catalysed eicosanoids, which in turn may
stimulate tumour cell growth (Carter et al., 1983; Noguchi
et al., 1993, 1995). On the contrary, n-3 fatty acids inhibit
both the cyclooxygenase and the lipoxygenase pathways
(Culp et al., 1979; Corey et al., 1983; Karmali, 1987). Also
gene expression and growth factor-mediated signal transduc-
tion may be modulated by fatty acids (Tiwari et al., 1991;
Distel et al., 1992; Fazio et al., 1992).
Correspondence: S Mollerup
Received 1 December 1995; revised 22 February 1996; accepted 27
February 1996
The epidermal growth factor (EGF) is involved in growth
control of many kinds of cells. EGF binds to the membrane-
associated 170 kDa EGF receptor (EGF-R). EGF binding
results in receptor dimerisation, thereby activating the
intrinsic receptor tyrosine kinase activity, causing its
phosphorylation and signal propagation to downstream
substrates. Tyrosine kinase activity of the receptor is a
prerequisite for EGF-mediated signal transduction (reviewed
in Ullrich and Schlessinger, 1990; van der Geer and Hunter,
1994). EGF-mediated signal transduction may be modulated
by PUFAs (Bandyopadhyay et al,. 1987, 1993; Casabiell et
al., 1991; Glasgow et al., 1992).
Recently, we reported a correlation between sensitivity
among different cell lines to the growth-inhibitory effect of
PUFAs in vitro and the ability of these fatty acids to reduce
tumour growth rates in vivo (Krokan et al., 1993; Mxhle et
al., 1995). Little is known about the role of PUFAs on
growth factor-mediated signal transduction during in vitro
carcinogenesis, especially fatty acids of the n-3 class. We have
developed an in vitro human multistep model suitable for
human epithelial carcinogenesis studies (Tveito et al 1989;
Haugen et al., 1990; Mollerup et al., 1996). The present study
was undertaken to investigate the influence of n-3
[eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA)] and n-6 [linoleic acid (LA) and arachidonic acid
(ARA)] PUFAs on EGF-mediated growth control during
human epithelial in vitro carcinogenesis.
Materials and methods
Chemicals
Dulbecco's modified Eagle Medium (DMEM)/F12 (1:1),
EGF, insulin, transferrin, hydrocortisone, sodium-selenite,
palmitic acid, stearic acid, linoleic acid, arachidonic acid,
eicosapentaenoic acid, docosahexaenoic acid, fatty acid-free
bovine serum albumin (BSA) (fraction V) and genistein were
all purchased from Sigma Chemical Company, St Louis, MO,
USA. Tyrphostin-47 (3,4-dihydroxy-a-cyanothiocinnama-
mide) was from Fluka Chemie AG, Buchs, Switzerland.
Fetal calf serum (FCS) was from Gibco BRL, and
[3H]thymidine was from NEN Research Products, Du Pont
de Nemour & Co., Boston, MA, USA.PUFA and in vitro carcinogenesis
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Cell lines and culture conditions
Immortalisation of human kidney epithelial cells by exposure
to Ni2" (IIHKE), and the subsequent transformation by v-
Ha-ras transfection (1THKEras) has been described pre-
viously (Tveito et al., 1989; Haugen et al., 1990; Mehle et al.,
1992). Recently, we have repeated the nickel-exposure
experiment and established a cell line (2IHKE) with several
properties of normal kidney epithelial cells. This cell line
exhibits EGF- and anchorage-dependence (unpublished
results). The kidney epithelial cell lines were cultured in
DMEM/F12 (1:1) medium, supplemented with EGF
(10 ng ml-1), insulin (5 jug ml), transferrin (5 mg ml-'),
hydrocortisone (36 ng ml-1), sodium selenite (5 ng ml-1)
and 1% (IIHKE and lTHKEras) or 5% FCS (2IHKE).
The cell lines were maintained at 37°C in humidified air
containing 5% carbon dioxide.
Stock solutions of fatty acids [free fatty acids: palmitic
acid (PA, C16:0), stearic acid (SA, C18:0), linoleic acid (LA,
C18:2, n-6), arachidonic acid (ARA, C20:4, n-6), eicosapen-
taenoic acid (EPA, C20:5, n-3), and docosahexaenoic acid
(DHA, C22:6, n-3)] were prepared in 99% ethanol, and
stored at -70°C under nitrogen for no longer than a month.
After addition of fatty acids, the medium was incubated for
1 h at 37°C in air containing 5% carbon dioxide, before
addition to cell cultures. Tyrosine kinase inhibitors (dissolved
in dimethyl sulphoxide) were added to cell cultures 1 h before
addition of fatty acids and EGF, and were present
throughout the incubation period.
DNA synthesis
The proliferative activity of the cells was measured by
estimating [3H]thymidine ([3H]TdR) incorporation into
DNA, essentially as previously described (Mollerup et al.,
1996). Cells were seeded in 24-well trays, at a density of 1-5
x 104 cells per well in DMEM/F12 medium supplemented
with FCS. Two days later the medium was replaced with
DMEM/F12 supplemented with 2.25 mg ml-1 fatty acid-free
BSA (fraction V) (serum-free medium, SFM) and the
indicated concentrations of fatty acids or tyrosine kinase
inhibitors (genistein or tyrphostin-47). [3H]TdR (2.5 mCi
ml-l' 1 mCi per well, 82.5 Ci mmol-1 specific activity) was
added 48 h later, and incubation continued for 4 h at 37°C.
Cells were then fixed in ice-cold methanol for 20 min,
followed by three washes in Hepes-buffered saline. Unin-
corporated [3H]TdR was extracted from the cells by
incubation in trichloroacetic acid (5%, w/v) for 20 min at
4°C followed by three washes in water. Cells were lysed in
0.5% sodium dodecyl sulphate (SDS), 0.25 M sodium
hydroxide at 60°C for 20 min. Cell lysates were transferred
to scintillation vials and radioactivity was measured by liquid
scintillation counting. P<0.05, Student's t-test, was consid-
ered statistically significant. Experiments were repeated
several times with similar results. Parallel experiments with
measurement of cell proliferation by cell counting gave
similar results (data not shown).
Immunoblotting
Cells were seeded in 35 mm dishes as a density of 0.75-1.5
x 105 cells per dish in DMEM/F12 and treated with tyrosine
kinase inhibitors as indicated above. Cells were then exposed
to 200 ng ml-1 EGF for 5 min at 37°C. The dishes were
washed three times in ice-cold Hepes-buffered saline, and
cellular proteins were solubilised in SDS-PAGE sample buffer
and denatured at 95°C for 5 min (Laemmli, 1970). Parallel
dishes were seeded for determination of protein content by
the method of Lowry et al. (1951).
Proteins were separated on 7.5% SDS-PAGE mini gels
(Bio Rad Mini-Protean II, Bio-Rad Laboratories, Richmond,
CA, USA) and transferred to Immobilon-P PVDF mem-
branes (Millipore Corporation, Bedford, MA, USA).
Tyrosine-phosphorylated proteins were detected with a
polyclonal phosphotyrosine-specific antibody (Mollerup et
al., 1996), followed by a secondary horseradish peroxidase-
linked antibody, and visualised by the enhanced chemilumi-
nescence detection kit (Amersham International, UK) and
exposure of autoradiography film (Kodak X-OMAT S).
Densitometric analysis of autoradiographic films was
performed on a Macintosh 7100/66AV computer using the
public domain NIH Image program.
Results
DNA synthesis in human kidney epithelial cell lines-response
to n-3 PUFAs
We have previously shown that n-3 and n-6 PUFAs inhibited
in vitro proliferation of human kidney epithelial cell lines in a
dose-dependent manner (Mehle et al., 1995). These experi-
ments were carried out in serum-containing culture media. In
order to investigate further the effect ofpolyunsaturated fatty
acids on cell proliferation in these cell lines, experiments were
a
c
0 ox M.) iu ^
oE E
0d
L---
o x.
. _c
Qa
a
I
"L.
40
30
15
0
I/
80
Fatty acid (gM)
b
c 20
0
O 15
O x o 10 _
._
5
Iz00
c
0
ox
06
._
vCL$ L---
o x
.c
c QL
a
I
C',
40
30
20
10
0
lI 7///
0 10 20 80
Fatty acid (gM)
C
0 10
Fatty acid (p
20 80
IM)
Figure 1 Effect ofn-3 PUFAs on [3H]thymidine incorporation in
2IHKE, 1IHKE and lTHKEras cells. Cells were exposed to
increasing concentrations ofEPA or DHA with and without EGF
in SFM for 48 h. [3H]TdR uptake was measured as described in
Materials and methods. Each point corresponds to the mean of
three estimations of acid-precipitable H (c.p.m.) at each
concentration of fatty acid. Error bars denote s.d. (a) 2IHKE,
(b) 1IHKE and (c) ITHKEras cells. (0) EPA without EGF; (0)
EPA + I0ngml-l EGF; (V) DHA without EGF, and (V) DHA
+ lOngml-1 EGF.
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_carried out under defined conditions. Figure la shows the
result of a [3H]thymidine incorporation experiment with
2IHKE cells incubated in the presence of increasing
concentrations of EPA and DHA w/w EGF. The 2IHKE
cell line showed a dual response to the n-3 PUFAs. In
addition to the observed growth inhibition at concentrations
>10 /iM, EPA and DHA stimulated proliferation of 2IHKE
cells significantly at low concentrations (1-5 /iM) in the
absence of EGF. In the presence of EGF, the growth
stimulation was even more profound with significantly
increased [3H]TdR incorporation at 1-5 gM EPA and 1-
10 gM DHA, indicating a synergistic effect ofn-3 PUFAs and
EGF on cell proliferation. The fatty acids inhibited growth at
concentrations > 10 gUM in the presence of EGF. Similar
results were obtained with normal adult human kidney
epithelial cells (data not shown).
IIHKE cells, an immortalised cell line that has abrogated
normal growth regulation in respect of EGF (Mollerup et al.,
1996), were growth inhibited at high concentrations of n-3
PUFAs either in the absence or presence of EGF (Figure lb).
Tumorigenic lTHKEras cells were only slightly inhibited by
the fatty acids (Figure lc). However, in both the IIHKE and
lTHKEras cell lines, no stimulatory effect of EPA and DHA
on [3H]TdR incorporation was observed, indicating that this
effect was abrogated during in vitro carcinogenesis.
Involvement of EGF receptor tyrosine kinase in n-3 PUFA
stimulation of cell proliferation
The results from Figure 1 indicated a synergistic effect of n-3
PUFAs and EGF on cell proliferation. To study the
mechanism(s) involved, the effect of specific inhibitors of
tyrosine kinase activity was investigated. 2IHKE cells were
incubated in the presence of tyrosine kinase inhibitors at
similar conditions to Figure 1. Cells were then exposed to
EGF for 5 min. Cellular extracts were subjected to
immunoblotting and probed with a phosphotyrosine-specific
antibody. As shown in Figure 2, a 5 min EGF pulse resulted
in tyrosine phosphorylation on the EGF-R and other cellular
proteins. Genistein, which is a general inhibitor of tyrosine
kinases (Akiyama et al., 1987), and the relatively specific
inhibitor of EGF-R tyrosine kinase activity, tyrphostin-47
(Gazit et al., 1989), inhibited EGF-induced tyrosine
phosphorylation dose-dependently. Genistein was a more
PUFA and in vitro carcinogenesis
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Figure 3 Effect of (a) genistein and (b) tyrphostin-47 on DHA-
stimulated [3H]thymidine incorporation in 2IHKE cells. Cells
were exposed to DHA in SFM for 48h with and without EGF,
and with and without genistein or tyrphostin-47. [3H]TdR uptake
(c.p.m.) was measured as in Figure 1. Open symbols denote
exposure without EGF and closed symbols with 10ngml-1 EGF.
In (a), (O and 0) without, and (V and V) with 25gM genistein,
and in (b), (L] and *) without, and (A and A) with 50pM
tyrphostin-47.
A
+ + + + - EGF B
Inhibitor(pM)
+ + + + +
- EGF-R -
Figure 2 Effect of (a) genistein and (b) tyrphostin-47 on EGF-induced tyrosine phosphorylation in 2IHKE cells. Cells were
incubated in the presence of genistein or tyrphostin-47 for 48h at the indicated concentrations. Cells were then exposed to EGF
(200ngml-1 for 5min). Cellular extracts were subjected to immunoblotting with a phosphotyrosine-specific antibody (see Materials
and methods). 'EGF-R' denotes position of EGF receptor in immunoblots with an anti-EGF receptor antibody.
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potent inhibitor of tyrosine kinase activity than tyrphostin-
47. The effect of the inhibitors on DHA-stimulated
proliferation of 2IHKE cells was studied. Genistein, at a
concentration of 25 /iM, inhibited proliferation and totally
abolished the stimulatory effect of DHA in the 2IHKE cells,
both in the absence and presence of EGF (Figure 3a). Under
similar conditions, tyrphostin-47, at a concentration of
50 gM, also abolished stimulation of DNA synthesis by
DHA, as shown in Figure 3b (tyrphostin-47 was not as
inhibitory to [3H]TdR incorporation as genistein). Densito-
metric scanning of the band corresponding to the EGF-R in
Figure 2 revealed that the phosphotyrosine content at 25 gM
genistein and 50 gM tyrphostin-47 was reduced to 32% and
43% of the controls respectively. Together, these data
indicate the involvement of EGF receptor tyrosine kinase in
the n-3 PUFA-induced stimulation of 2IHKE cell prolifera-
tion.
n-6 PUFAs exert an effect similar to n-3 PUFAs on DNA
synthesis in 2IHKE cells
The n-6 PUFAs LA and ARA were administered to 2IHKE
cells under defined conditions similar to the n-3 fatty acid
experiment (Figure 4). Low concentrations of either LA or
ARA stimulated proliferation. In the absence of EGF,
[3H]TdR incorporation was significantly increased at 1-
5 gM LA and 1-2.5 gM ARA respectively. Again, a
synergistic effect of EGF was observed. In the case of LA
and EGF a broader stimulatory concentration range (1-
20 yM) was demonstrated, whereas [3H]TdR incorporation
was significantly increased at 1-2.5 gM ARA in the presence
of EGF. As in the case of the n-3 PUFAs, high
concentrations of LA or ARA inhibited cell proliferation.
Saturatedfatty acids
In contrast to the n-3 and n-6 PUFAs, the saturated fatty
acids palmitic and stearic acid did not stimulate proliferation
of 2IHKE cells at any concentrations tested (Figure 5).
Rather, these fatty acids inhibited cell proliferation in a dose-
dependent manner, PA being more inhibitory than SA.
Discussion
We report here that low concentrations of n-3 PUFAs
stimulated proliferation of the 2IHKE cell line under defined
growth conditions. In the presence of EGF, the growth-
stimulatory effect of PUFAs was even more profound.
Specific tyrosine kinase inhibitors [genistein and tyrphostin-
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Figure 4 Effect ofn-6 PUFAs on [3H]thymidine incorporation in
2IHKE cells. Cells were exposed to increasing concentrations of
LA or ARA with and without EGF in SFM for 48h. [3H]TdR
uptake (c.p.m.) was measured as in Figure 1. (0) LA without
EGF, (0) LA with lOngml-l EGF, (V) ARA without EGF,
and (V) ARA with lOngml-l EGF.
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Figure 5 Effect of saturated fatty acids on [3H]thymidine
incorporation in 2IHKE cells. Cells were exposed to increasing
concentrations of PA or SA with and without EGF in SFM for
48h. [3H]TdR uptake (c.p.m.) was measured as in Figure 1. (0)
PA without EGF, (-) PA with lOngml-1 EGF, (V) SA without
EGF, and (V) SA with lOngmlF- EGF.
47 (Akiyama et al., 1987; Gazit et al., 1989)] inhibited EGF-
induced protein tyrosine phosphorylation. In addition,
genistein and tyrphostin-47 totally abrogated the growth-
stimulatory effect ofDHA, both in the absence or presence of
EGF, suggesting interaction with tyrosine kinase signal
transduction pathways especially involving the EGF-R. This
is in agreement with the reported findings that an EGF-R-
blocking antibody caused suppression of LA-stimulated
proliferation of a human prostate cancer cell line
(DU145M) in serum-free medium (Connolly and Rose,
1992). The possibility that other factors involved in the
growth control of the 2IHKE cells may be affected by
genistein and tyrphostin-47, however, cannot be excluded. n-6
and n-9 PUFAs have been reported to inhibit PDGF receptor
tyrosine kinase activity in both intact cells and membrane
preparations (Tomaska and Resnick, 1993). Treatment of the
2IHKE cells with n-3 PUFAs at growth-stimulatory
conditions (in the absence of EGF) did not affect the EGF-
induced level of cellular tyrosine phosphorylation (data not
shown).
PUFAs have been shown to modulate EGF-mediated
signal transduction (Bandyopadhyay et al., 1987, 1993;
Casabiell et al., 1991). These studies included fatty acids of
the n-6, n-7 and n-9 classes. However, studies on the action of
n-3 PUFAs on signal transduction are limited, although
modulation of the catalytic activity of protein kinase C and
type I cAMP-dependent protein kinase has been demon-
strated (Speizer et al., 1991).
Interestingly, we observed a similar growth-stimulatory
effect of low concentrations of both n-3 and n-6 PUFAs on
2IHKE cells, which have retained several phenotypical
features of normal cells. Studies have shown that human
prostate (PC-3) and breast (MDA-MB-231) cancer cell lines
were growth stimulated by low concentrations of n-6 PUFA
(LA) under defined conditions. However, in contrast to our
results low concentrations of the n-3 PUFAs, EPA and DHA
were growth inhibitory (Rose and Connolly, 1990, 1991). LA
and ARA also stimulated cell proliferation of murine colon
adenocarcinomas (Hussey and Tisdale, 1994). Perfusion of
Morris hepatomas (7288CTC) in situ with donor whole blood
containing added PUFAs resulted in an increased (n-6) or
decreased (n-3) rate of DNA synthesis (Sauer and Dauchy,
1992). The increase in DNA synthesis rate was observed at
high plasma concentrations of n-6 PUFAs (200-600 gM). In
vivo studies have shown that PUFAs of the n-6 class may
enhance both chemically induced and transplanted tumour
development and that PUFAs of the n-3 class frequently
exert an opposite effect, inhibiting tumour development
(Roebuck et al., 1981; Karmali et al., 1984; Braden and
Carroll, 1986; Borgeson et al., 1989; Rose et al., 1993;
Mehle et al., 1995). The in vivo differences have been
u
_
_
_
_
/ z ..
20
/ I., 80
_-PUFA and in vitro carcinogenesis
S Mollerup and A Haugen
617
explained by differences in eicosanoid synthesis and different
lipid peroxidation potential (Gonzalez et al., 1993; Noguchi
et al., 1995). Our short-term studies on growth-regulatory
control by PUFAs does not account for long-term in vivo
effects, and a clear correlation between in vivo and in vitro
data can therefore not be expected.
The stimulatory effect of the n-3 and n-6 PUFAs was
confined to the 2IHKE cell line, which shows apparent
normal EGF-mediated growth-regulatory control (unpub-
lished data). In general, PUFAs have been implicated in
promotion stages of carcinogenesis (Aylsworth et al., 1984;
Reddy et al., 1991; Ronai et al., 1991). Our data on the
action of low concentrations of PUFAs are consistent with a
multistep carcinogenesis model where stimulation of clono-
genic growth of initiated cells (2IHKE) will enhance the
possibility of a hit by secondary carcinogens, and this in turn
may result in tumorigenic conversion. The growth-stimula-
tory effect of PUFAs correlates with normal EGF growth-
regulatory control. In our in vitro model, the 1IHKE and
lTHKEras cell lines showed a marked loss of stimulatory
response to low concentrations of PUFAs, indicating an
alteration taking place during the in vitro carcinogenic
process. These results correlate with our previous observa-
tions that the 1IHKE and lTHKEras cell lines have
abrogated normal growth-regulatory control in respect of
mitogenic response to EGF and expression of the EGF-R
(Mollerup et al., 1996). The proliferation of normal cells is a
highly regulated process, controlled by the interplay of
growth-inducing and growth-inhibitory signals. Although
normal human kidney epithelial cells are stimulated by
PUFAs in vitro (data not shown), this characteristic might
not be expressed in vivo, indicating no conflict with the
perception of PUFAs functioning as tumour promoters.
Using defined growth conditions, we observed an
increased resistance towards the growth-inhibitory effect of
high concentrations of DHA with increased transformation/
malignant potential of the human kidney epithelial cell lines
(2IHKE< lIHKE< lTHKEras). Sensitivity to the growth-
inhibitory effect of PUFAs varies considerably between
different cell types (Krokan et al., 1993; Mxhle et al.,
1995). In contrast to the data presented here, it has been
reported that normal cells may be more resistant to the
inhibitory effect than tumour cells in vitro (Begin et al., 1986;
Krokan et al., 1993), and it might be expected that sensitivity
should increase during development of the transformed
phenotype within cell lines with a common origin.
In conclusion, we have shown that n-3 and n-6 fatty acids
may stimulate the proliferation of immortalised human
kidney epithelial cells with apparent normal EGF growth-
regulatory control. This effect apparently involves EGF-R
tyrosine kinase activity. Furthermore, our results demonstrate
that the stimulatory growth response to the PUFAs was
abrogated during in vitro transformation of the cell lines.
Further studies are needed to determine the specific
mechanism(s) involved.
Abbreviations
EGF, epidermal growth factor; EGF-R, epidermal growth factor
receptor; PA, palmitic acid (C16:0); SA, stearic acid (C18:0); LA,
linoleic acid (C18:2, n-6); ARA, arachidonic acid (C20:4, n-6);
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